Fire Point, maker of Ukraine’s Flamingo cruise missile, is in talks with European firms on a new air defense system intended ...
By Max Hunder and Daniel Flynn April 6 (Reuters) - Fire Point, maker of Ukraine's Flamingo cruise missile, is in talks with ...
April 6 - Fire Point, maker of Ukraine's Flamingo cruise missile, is in talks with European companies to launch a new air ...
The Flamingo missile, built by controversial defense manufacturer Fire Point, has only been used by Kyiv on a handful of ...
16h
Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential
Statistically significant immune response and recurrence rate data is the basis for new claims recently filed that GLSI-100 clinically benefits non-HLA-A*02 patients, which the Company believes ...
Greenwich LifeSciences (GLSI) stock is a "Buy" as phase 3 FLAMINGO-01 advances in HER2-positive breast cancer with two major ...
By Daniel FlynnFire Point, maker of Ukraine's Flamingo cruise missile, is in talks with European companies to launch ​a new air defence ...
The Ukrainian company Fire Point, known for developing the Flamingo cruise missile, has begun negotiations with leading ...
At the heart of the issue is the adjusted margin metric, which is seen as an analog for profits in MakeMyTrip's financial ...
Russian glide bomb attack on Kramatorsk kills 3, including 13-year-old boy, governor says * Pro-Ukrainian partisans disable ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results